These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28148938)

  • 41. Drug companies in US spent millions pushing for weight loss drug approvals, investigative report finds.
    McCarthy M
    BMJ; 2015 Apr; 350():h2138. PubMed ID: 25902800
    [No Abstract]   [Full Text] [Related]  

  • 42. Market watch: Upcoming market catalysts in Q3 2016.
    Ranj T
    Nat Rev Drug Discov; 2016 Jul; 15(7):449. PubMed ID: 27282354
    [No Abstract]   [Full Text] [Related]  

  • 43. The strange allure of state "right-to-try" laws.
    Zettler PJ; Greely HT
    JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
    [No Abstract]   [Full Text] [Related]  

  • 44. Looking for a miracle.
    Marchant J
    New Sci; 2000 Jun; 166(2244):16-7. PubMed ID: 11902203
    [No Abstract]   [Full Text] [Related]  

  • 45. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 46. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New drugs for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 2012 Nov; 54(1403):89-91. PubMed ID: 23183318
    [No Abstract]   [Full Text] [Related]  

  • 48. An audience with Tatiana Prowell. Interviewed by Asher Mullard.
    Prowell T
    Nat Rev Drug Discov; 2014 Jun; 13(6):410-1. PubMed ID: 24875091
    [No Abstract]   [Full Text] [Related]  

  • 49. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
    Moss RW
    New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
    [No Abstract]   [Full Text] [Related]  

  • 50. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent developments help the defense of drug companies in 10b-5 cases.
    Salpeter AN; Hutchins H
    Food Drug Law J; 1996; 51(3):345-53. PubMed ID: 11797711
    [No Abstract]   [Full Text] [Related]  

  • 52. Executive summary from the final reports of the National Committee to Review Current Procedures for Approval of New Drugs for Cancer and AIDS.
    Oncology (Williston Park); 1991 Apr; 5(4):16, 18-9. PubMed ID: 1831034
    [No Abstract]   [Full Text] [Related]  

  • 53. Expanded access to investigational drugs for treatment use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accelerated approval seen as triumph and roadblock for cancer drugs.
    Susman E
    J Natl Cancer Inst; 2004 Oct; 96(20):1495-6. PubMed ID: 15494596
    [No Abstract]   [Full Text] [Related]  

  • 56. FDA finds new ways to speed treatment to patients.
    Flieger K
    FDA Consum; 1993 Oct; 27(8):14-8. PubMed ID: 10129048
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes in FDA drug classification and priority review policy.
    Crawford SY
    Am J Hosp Pharm; 1992 Oct; 49(10):2383, 2386. PubMed ID: 1442812
    [No Abstract]   [Full Text] [Related]  

  • 58. 124 drugs currently in development.
    AIDS Patient Care STDS; 1998 Feb; 12(2):149. PubMed ID: 11361916
    [No Abstract]   [Full Text] [Related]  

  • 59. The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
    Birnkrant D; Cox E
    N Engl J Med; 2009 Dec; 361(23):2204-7. PubMed ID: 19884645
    [No Abstract]   [Full Text] [Related]  

  • 60. Conflicting signals on US accelerated approvals.
    Fox JL
    Nat Biotechnol; 2005 Sep; 23(9):1027-8. PubMed ID: 16151377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.